Skip to main content
Erschienen in: Heart and Vessels 2/2020

09.09.2019 | Original Article

Regulatory T cells suppress the expression of COX-2 in vulnerable plaque

verfasst von: Kai Zhang, Jing Kong, Bin Liu, Xiao Meng

Erschienen in: Heart and Vessels | Ausgabe 2/2020

Einloggen, um Zugang zu erhalten

Abstract

COX-2 contributes to local inflammation in atherosclerotic lesions. Regulatory T cells (Tregs) enhance the stability of atherosclerotic plaques. The aim of this study was to detect the potential relationship between Tregs and COX-2 in vulnerable plaques. Thirty ApoE −/− mice were fed a high-fat diet, and a silastic perivascular collar was placed around the right common carotid artery to induce vulnerable plaques. Eight weeks after collar placement, the mice were divided randomly into three groups: control, PBS, and Treg groups. Four weeks later, the right common carotid arteries were collected to detect the expression of COX-2. The results showed that Tregs significantly suppressed the expression of COX-2 in vulnerable plaques. In an in vitro experiment, RAW264.7 cells were divided randomly into three groups, which were precultured without T cells or with CD4 + CD25- T cells or Tregs for 48 h with an anti-CD3 antibody; then the cells were stimulated with LPS for 24 h. The RAW264.7 cells were harvested for RT-PCR and western blot assays and the results showed that Tregs downregulated COX-2 expression in RAW264.7 cells. Therefore, Tregs inhibited the expression of COX-2 in vulnerable plaques and macrophages, and COX-2 inhibition may be an important effect of Tregs that results in atherosclerotic plaque stabilization.
Literatur
1.
Zurück zum Zitat Libby P (2012) Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 32(9):2045–2051CrossRef Libby P (2012) Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol 32(9):2045–2051CrossRef
2.
Zurück zum Zitat Yang T, Sun D, Huang YG, Smart A, Briggs JP, Schnermann JB (1999) Differential regulation of COX-2 expression in the kidney by lipopolysaccharide: role of CD14. Am J Physiol 277(1 Pt 2):F10–16PubMed Yang T, Sun D, Huang YG, Smart A, Briggs JP, Schnermann JB (1999) Differential regulation of COX-2 expression in the kidney by lipopolysaccharide: role of CD14. Am J Physiol 277(1 Pt 2):F10–16PubMed
3.
Zurück zum Zitat Zahner G, Schaper M, Panzer U, Kluger M, Stahl RA, Thaiss F, Schneider A (2009) Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation. Biochem J 422(3):563–570CrossRef Zahner G, Schaper M, Panzer U, Kluger M, Stahl RA, Thaiss F, Schneider A (2009) Prostaglandin EP2 and EP4 receptors modulate expression of the chemokine CCL2 (MCP-1) in response to LPS-induced renal glomerular inflammation. Biochem J 422(3):563–570CrossRef
4.
Zurück zum Zitat Narasimha AJ, Watanabe J, Ishikawa TO, Priceman SJ, Wu L, Herschman HR, Reddy ST (2010) Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null mice. Arterioscler Thromb Vasc Biol 30(2):260–268CrossRef Narasimha AJ, Watanabe J, Ishikawa TO, Priceman SJ, Wu L, Herschman HR, Reddy ST (2010) Absence of myeloid COX-2 attenuates acute inflammation but does not influence development of atherosclerosis in apolipoprotein E null mice. Arterioscler Thromb Vasc Biol 30(2):260–268CrossRef
5.
Zurück zum Zitat Kuge Y, Takai N, Ishino S, Temma T, Shiomi M, Saji H (2007) Distribution profiles of membrane Type-1 matrix metalloproteinase (MT1-MMP), matrix metalloproteinase-2 (MMP-2) and cyclooxygenase-2 (COX-2) in rabbit atherosclerosis: comparison with plaque instability analysis. Biol Pharm Bull 30(9):1634–1640CrossRef Kuge Y, Takai N, Ishino S, Temma T, Shiomi M, Saji H (2007) Distribution profiles of membrane Type-1 matrix metalloproteinase (MT1-MMP), matrix metalloproteinase-2 (MMP-2) and cyclooxygenase-2 (COX-2) in rabbit atherosclerosis: comparison with plaque instability analysis. Biol Pharm Bull 30(9):1634–1640CrossRef
6.
Zurück zum Zitat Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345–352CrossRef Sakaguchi S (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6:345–352CrossRef
7.
Zurück zum Zitat Mor A, Planer D, Luboshits G, Afek A, Metzger S, Chajek-Shaul T, Keren G, George J (2007) Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 27(4):893–900CrossRef Mor A, Planer D, Luboshits G, Afek A, Metzger S, Chajek-Shaul T, Keren G, George J (2007) Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler Thromb Vasc Biol 27(4):893–900CrossRef
8.
Zurück zum Zitat Meng X, Li W, Yang J, Zhang K, Qin W, An G, Gao F, Wang Y, Zhang C, Zhang Y (2013) Regulatory T cells prevent plaque disruption in apolipoprotein E-knockout mice. Int J Cardiol 168(3):2684–2692CrossRef Meng X, Li W, Yang J, Zhang K, Qin W, An G, Gao F, Wang Y, Zhang C, Zhang Y (2013) Regulatory T cells prevent plaque disruption in apolipoprotein E-knockout mice. Int J Cardiol 168(3):2684–2692CrossRef
9.
Zurück zum Zitat Cheng C, Noordeloos AM, Jeney V, Soares MP, Moll F, Pasterkamp G, Serruys PW, Duckers HJ (2009) Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 119:3017–3027CrossRef Cheng C, Noordeloos AM, Jeney V, Soares MP, Moll F, Pasterkamp G, Serruys PW, Duckers HJ (2009) Heme oxygenase 1 determines atherosclerotic lesion progression into a vulnerable plaque. Circulation 119:3017–3027CrossRef
10.
Zurück zum Zitat Yand JM, Dong M, Meng X, Zhao YX, Yang XY, Liu XL, Hao PP, Li JJ, Wang XP, Zhang K, Gao F, Zhao XQ, Zhang MX, Zhang Y, Zhang C (2013) Angiotensin-(1–7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells. Arterioscler Thromb Vasc Biol 33(8):1978–1985CrossRef Yand JM, Dong M, Meng X, Zhao YX, Yang XY, Liu XL, Hao PP, Li JJ, Wang XP, Zhang K, Gao F, Zhao XQ, Zhang MX, Zhang Y, Zhang C (2013) Angiotensin-(1–7) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells. Arterioscler Thromb Vasc Biol 33(8):1978–1985CrossRef
11.
Zurück zum Zitat Hui Y, Ricciotti E, Crichton I, Yu Z, Wang D, Stubbe J, Wang M, Puré E, FitzGerald GA (2010) Targeted deletions of cyclooxygenase-2 and atherogenesis in mice. Circulation 121(24):2654–2660CrossRef Hui Y, Ricciotti E, Crichton I, Yu Z, Wang D, Stubbe J, Wang M, Puré E, FitzGerald GA (2010) Targeted deletions of cyclooxygenase-2 and atherogenesis in mice. Circulation 121(24):2654–2660CrossRef
12.
Zurück zum Zitat Kim CK, Cho DH, Lee KS, Lee DK, Park CW, Kim WG, Lee SJ, Ha KS, Goo Taeg O, Kwon YG, Kim YM (2012) Ginseng berry extract prevents atherogenesis via anti-inflammatory action by upregulating phase ii gene expression. Evid Based Complement Alternat Med 2012:490301PubMedPubMedCentral Kim CK, Cho DH, Lee KS, Lee DK, Park CW, Kim WG, Lee SJ, Ha KS, Goo Taeg O, Kwon YG, Kim YM (2012) Ginseng berry extract prevents atherogenesis via anti-inflammatory action by upregulating phase ii gene expression. Evid Based Complement Alternat Med 2012:490301PubMedPubMedCentral
13.
Zurück zum Zitat Cipollone F, Prontera C, Pini B, Marini M, Fazia M, De Cesare D, Iezzi A, Ucchino S, Boccoli G, Saba V, Chiarelli F, Cuccurullo F, Mezzetti A (2001) Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation 104(8):921–927CrossRef Cipollone F, Prontera C, Pini B, Marini M, Fazia M, De Cesare D, Iezzi A, Ucchino S, Boccoli G, Saba V, Chiarelli F, Cuccurullo F, Mezzetti A (2001) Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E(2)-dependent plaque instability. Circulation 104(8):921–927CrossRef
14.
Zurück zum Zitat Dietel B, Cicha I, Voskens CJ, Verhoeven E, Achenbach S, Garlichs CD (2013) Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells. Atherosclerosis 230(1):92–99CrossRef Dietel B, Cicha I, Voskens CJ, Verhoeven E, Achenbach S, Garlichs CD (2013) Decreased numbers of regulatory T cells are associated with human atherosclerotic lesion vulnerability and inversely correlate with infiltrated mature dendritic cells. Atherosclerosis 230(1):92–99CrossRef
15.
Zurück zum Zitat Erdman SE, Sohn JJ, Rao VP, Nambiar PR, Ge Z, Fox JG, Schauer DB (2005) CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in Apc Min/+ mice. Cancer Res 65(10):3998–4004CrossRef Erdman SE, Sohn JJ, Rao VP, Nambiar PR, Ge Z, Fox JG, Schauer DB (2005) CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in Apc Min/+ mice. Cancer Res 65(10):3998–4004CrossRef
16.
Zurück zum Zitat Browatzki M, Larsen D, Pfeiffer CA, Gehrke SG, Schmidt J, Kranzhofer A, Katus HA, Kranzhofer R (2005) Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner. J Vasc Res 42:415–423CrossRef Browatzki M, Larsen D, Pfeiffer CA, Gehrke SG, Schmidt J, Kranzhofer A, Katus HA, Kranzhofer R (2005) Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner. J Vasc Res 42:415–423CrossRef
17.
Zurück zum Zitat Solomon SD, Pfeffer MA, McMurray JJ, Fowler R, Finn P, Levin B, Eagle C, Hawk E, Lechuga M, Zauber AG, Bertagnolli MM, Arber N, Wittes J, APC, and PreSAP Trial Investigators (2006) Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation 114(10):1028–1035CrossRef Solomon SD, Pfeffer MA, McMurray JJ, Fowler R, Finn P, Levin B, Eagle C, Hawk E, Lechuga M, Zauber AG, Bertagnolli MM, Arber N, Wittes J, APC, and PreSAP Trial Investigators (2006) Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas. Circulation 114(10):1028–1035CrossRef
18.
Zurück zum Zitat Jacob S, Laury-Kleintop L, Lanza-Jacoby S (2008) The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in ApoE-/- mice. J Surg Res 146(1):135–142CrossRef Jacob S, Laury-Kleintop L, Lanza-Jacoby S (2008) The select cyclooxygenase-2 inhibitor celecoxib reduced the extent of atherosclerosis in ApoE-/- mice. J Surg Res 146(1):135–142CrossRef
19.
Zurück zum Zitat Vidal C, Gómez-Hernández A, Sánchez-Galán E, González A, Ortega L, Gómez-Gerique JA, Tuñón J, Egido J (2007) Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis. J Pharmacol Exp Ther 320(1):108–116CrossRef Vidal C, Gómez-Hernández A, Sánchez-Galán E, González A, Ortega L, Gómez-Gerique JA, Tuñón J, Egido J (2007) Licofelone, a balanced inhibitor of cyclooxygenase and 5-lipoxygenase, reduces inflammation in a rabbit model of atherosclerosis. J Pharmacol Exp Ther 320(1):108–116CrossRef
20.
Zurück zum Zitat Bea F, Blessing E, Bennett BJ, Kuo CC, Campbell LA, Kreuzer J, Rosenfeld ME (2003) Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis. Cardiovasc Res 60(1):198–204CrossRef Bea F, Blessing E, Bennett BJ, Kuo CC, Campbell LA, Kreuzer J, Rosenfeld ME (2003) Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis. Cardiovasc Res 60(1):198–204CrossRef
21.
Zurück zum Zitat Raval M, Frank PG, Laury-Kleintop L, Yan G, Lanza-Jacoby S (2010) Celecoxib combined with atorvastatin prevents progression of atherosclerosis. J Surg Res 163(2):e113–122CrossRef Raval M, Frank PG, Laury-Kleintop L, Yan G, Lanza-Jacoby S (2010) Celecoxib combined with atorvastatin prevents progression of atherosclerosis. J Surg Res 163(2):e113–122CrossRef
22.
Zurück zum Zitat Pang Y, Gan L, Wang X, Su Q, Liang C, He P (2019) Celecoxib aggravates atherogenesis and upregulates leukotrienes in ApoE-/- mice and lipopolysaccharide-stimulated RAW264.7 macrophages. Atherosclerosis 284:50–58CrossRef Pang Y, Gan L, Wang X, Su Q, Liang C, He P (2019) Celecoxib aggravates atherogenesis and upregulates leukotrienes in ApoE-/- mice and lipopolysaccharide-stimulated RAW264.7 macrophages. Atherosclerosis 284:50–58CrossRef
23.
Zurück zum Zitat Yu Y, Ricciotti E, Scalia R, Tang SY, Grant G, Yu Z, Landesberg G, Crichton I, Wu W, Puré E, Funk CD, FitzGerald GA (2012) Vascular COX-2 modulates blood pressure and thrombosis in mice. Sci Transl Med 4(132):132ra54CrossRef Yu Y, Ricciotti E, Scalia R, Tang SY, Grant G, Yu Z, Landesberg G, Crichton I, Wu W, Puré E, Funk CD, FitzGerald GA (2012) Vascular COX-2 modulates blood pressure and thrombosis in mice. Sci Transl Med 4(132):132ra54CrossRef
24.
Zurück zum Zitat Linton MF, Fazio S (2004) Cyclooxygenase-2 and inflammation in atherosclerosis. Curr Opin Pharmacol 4(2):116–123CrossRef Linton MF, Fazio S (2004) Cyclooxygenase-2 and inflammation in atherosclerosis. Curr Opin Pharmacol 4(2):116–123CrossRef
25.
Zurück zum Zitat Ross S, Eikelboom J, Anand SS, Eriksson N, Gerstein HC, Mehta S, Connolly SJ, Rose L, Ridker PM, Wallentin L, Chasman DI, Yusuf S, Paré G (2014) Association of cyclooxygenase-2 genetic variant with cardiovascular disease. Eur Heart J 35(33):2242–2248CrossRef Ross S, Eikelboom J, Anand SS, Eriksson N, Gerstein HC, Mehta S, Connolly SJ, Rose L, Ridker PM, Wallentin L, Chasman DI, Yusuf S, Paré G (2014) Association of cyclooxygenase-2 genetic variant with cardiovascular disease. Eur Heart J 35(33):2242–2248CrossRef
Metadaten
Titel
Regulatory T cells suppress the expression of COX-2 in vulnerable plaque
verfasst von
Kai Zhang
Jing Kong
Bin Liu
Xiao Meng
Publikationsdatum
09.09.2019
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 2/2020
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-019-01491-1

Weitere Artikel der Ausgabe 2/2020

Heart and Vessels 2/2020 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.